Success Stories: Jordanian Ph.D. in Pharmaceutics Achieves NIW Approval Through NAILG’s Lead
Client’s Testimonial:
“Thank you so much for your efforts! You guys are great; I am so happy I got the chance to work with you. It was not an easy process for all of us, but I noticed your hard work and how well the process is organized. I wish you all the best and looking forward to my next step with you.”
On November 25th, 2024, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist III in the Field of Pharmaceutical Science (Approval Notice).
General Field: Pharmaceutical Science
Position at the Time of Case Filing: Scientist III
Country of Origin: Jordan
State of Residence at the Time of Filing: California
Approval Notice Date: November 25th, 2024
Processing Time: 13 months, 5 days
Case Summary:
Our client from Jordan holds a Ph.D. in Pharmaceutics and Pharmacokinetics and has made remarkable strides in her field of expertise. With 10 peer-reviewed journal articles, including four as the first author and one book chapter her research has earned recognition in the top journals in her field. Her work has been cited 147 times, underscoring the significant impact it has had within the scientific community.
Her research focuses on developing methods to purify, characterize, quantify, and formulate biosynthetic compounds to improve the efficacy, safety, and sustainability of products like medications, cosmetics, polymers, and fuels while promoting clean chemistry. By advancing clean chemistry practices and upholding the highest standards of quality, her research plays a pivotal role in improving national health and safety.
Her expertise has garnered significant support, including funding from prestigious institutions such as the U.S. National Science Foundation, the National Institutes of Health, and the National Aeronautics and Space Administration (NASA), further highlighting the national importance of her work. These funds support projects that conduct scientific research for the betterment of society, particularly in areas relating to health and medicine.
With 2 letters of recommendation affirming her exceptional contributions, we were able to present a compelling case to the USCIS. Below is an excerpt from the letter:
“Therefore, [client] has shown on countless occasions why she is an unparalleled scientist in her field. In light of her industrious publication record, her prestigious academic qualifications, and her meaningful research, [client] is a central actor in achieving further advancements in her field.”
Building on our track record of over 32,000 successful cases, we proudly secured her NIW approval without issues. We are glad to be a part of her success journey and look forward to her continued success.

